Pfizer To Pay $190 Million to Settle Suit Over Epilepsy Drug -Reuters
22 April 2014 - 7:52AM
Dow Jones News
Pfizer Inc. (PFE) has agreed to pay $190 million to settle a
lawsuit involving Neurontin, the drug maker's epilepsy drug,
Reuters reported Monday on its website, citing court documents.
Plaintiffs in the suit, filed in 2002, had claimed Pfizer
delayed generic versions of the drug from the market.
Full story at:
www.reuters.com/article/2014/04/21/usa-antitrust-pfizer-idUSL2N0ND17020140421
Write to nymonitoring@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2024 to May 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From May 2023 to May 2024